98 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Request for Proposals: 2014 American Association for Dental Research Sjögren’s Syndrome Foundation Student Fellowship
Supported by Sjögren’s Syndrome Foundation
Deadline: October 8, 2013
Research proposals are now being accepted for the 2014 AADR Sjögren’s Syndrome Foundation Student Fellowship. This Fellowship is supported by the Sjögren’s Syndrome Foundation (SSF) and is offered to encourage research in the field of Sjögren’s Syndrome.
Founded in 1983, the SSF provides patients with practical information and coping strategies that minimize the effects of Sjögren's syndrome. In addition, the Foundation is the clearinghouse for medical information and is the recognized national advocate for Sjögren's syndrome. The Fellowship consists of a stipend of $4,000. Funds are not to be used to pay indirect, or institutional overhead costs.
The recipient will be announced at the 43rd Annual Meeting of the AADR in Charlotte, North Carolina, USA, March 19-22, 2014.
Eligibility:
Awards are open to both graduate and undergraduate students working towards a DDS, DMD, or PhD and are enrolled in an accredited institution within the U.S. Students must be sponsored by a faculty member at that institution. The Fellowship must be utilized between March 2014 and June 2015
Candidates MUST be AADR members.
Application Receipt Deadline: October 8, 2013
Inquiries and Applications are sent electronically in one PDF package to:
Sheri S. Herren IADR/AADR Strategic Programs Manager Email:sherren@aadronline.org
Wipe Out Kids’ Cancer, Inc. Research Grant Program
Application deadline: August 30, 2013
Wipe Out Kids’ Cancer, Inc. (WOKC) is a Dallas-based nonprofit organization founded in 1980 dedicated to raising awareness and funding pediatric cancer research on a national basis. WOKC’s mission is to work relentlessly for the day when all children are living cancer free.
One of the main goals of WOKC is to find cures through research. To meet this goal, WOKC provides grants to support meritorious research ranging from basic laboratory investigation to clinical management of pediatric cancers. For all awarded grants, collaboration with a pediatric cancer treatment center and an institution with basic and/or clinical research programs are encouraged.
Research Grants
Policies and Guidelines
Research Grants are offered to encourage the development of new information that contributes to the understanding, treatment, and cure of pediatric cancers. In addition, consideration will be given to those projects that provide insight into information that may contribute to the development of new therapies for pediatric cancers. All proposals must be hypothesis driven, and sufficient preliminary data must be provided to justify the WOKC support. Information derived from these studies should have high potential for sustainable future support from other funding agencies, such as the National Institutes of Health (NIH).
Research Grant applications should focus on basic science research or clinical research. Those proposals that include methodologies requiring sampling of materials from human subjects will be considered under this mechanism only if the sampling method constitutes minimal patient risk and are approved by the clinical/research institutions internal review board. All other projects utilizing human subjects must submit a Clinical Research Letter of Intent.
Applications for Research Grants are being accepted with the following stipulations:
Funding amount from $50,000 up to $150,000, including no more than 8% indirect costs, may be requested.
Grants may be approved for up to a 1 year period of funding.
Because grants cover only one year of research, likelihood of future funding from other sources will be considered and should be explained by the applicant.
Applicants must be independent investigators, or clinical or research receiving direct oversight/mentorship by an independent investigator.
Applicants need not be U.S. Citizens or hold a U.S. permanent visa to apply for this award.
International applicants and institutions are required to submit additional information in accordance with U.S. anti-terror restrictions.
SUBMISSION GUIDELINES
Application Deadline: August 30, 2013 at 5:00pm (Eastern Time)
Applications must be sent electronically with any signatures scanned to Evelyn Costolo at ecostolo@wokc.org. Hard copies will not be accepted.
Do not submit an incomplete application. An application will be considered incomplete if it fails to comply with instructions or if the material is insufficient to permit adequate review.
Revisions, insertions or appendices to applications will not be accepted after the receipt date unless agreed to by WOKC’s Grants Committee. Even if a part of an application is approved for late submission, there is no guarantee that the application will be reviewed. Only Human Subjects Certification, Use of Animals Certification, and Recombinant DNA Approval will be accepted apart from the body of the grant application if they are not available at time of submission.
Requests to submit supplemental data must be received before November 1st.
Alzheimer's Drug Discovery Foundation Young Investigator Scholarships for the 14th International Conference on Alzheimer's Drug Discovery
Ten ADDF Young Investigator Scholarships will be presented. Each of these 10 scholarships provides:
A single registration to attend the conference
Opportunity to present a poster at the conference
Name recognition in the program and on the conference website
Scholarship recipients are expected to attend the 14th International Conference on Alzheimer's Drug Discovery to receive the award.
ELIGIBILITY REQUIREMENTS
The applicant must be a graduate student or a postdoctoral fellow. Postdoctoral applicants should have no more than four years of postdoctoral training including postdoctoral training at other institutions. Physician-scientists are eligible to apply. The program has no geographic restrictions. Women and minorities are strongly encouraged to apply.
DEADLINE
All applications must be submitted by July 19, 2013. Winners will be announced via email.
APPLICATION
The following materials must be submitted for consideration by the ADDF’s Young Investigator Scholarship Review Committee:
Application Form (sumbitted online)
Current curriculum vitae that includes a list of publications (by email to sclassen@alzdiscovery.org)
AASLD/LIFER Clinical and Translational Research Fellowship in Liver Diseases Award
The AASLD/LIFER Clinical and Translational Research Fellowship in Liver Diseases Award is a one-year award of $75,000 intended to foster career development for an individual outside North America to perform clinical research within the United States in a liver-related area and who has shown commitment to excellence at an early stage of his or her research study. The award ensures that a significant portion of a young investigator's time is protected for research, with an overall objective of enabling the investigator to develop an independent and productive research career in liver disease. ELIGIBILITY
In order to be eligible for this award, the applicant must adhere to the following guidelines:
1. Applicant must possess a doctoral degree, either an MD or equivalent and/or a PhD from an institution outside North America.
2. At the start of the award period, MD applicants must be within four years of completing clinical residency or fellowship training (whichever ends more recently), and PhD applicants must be within four years of the receipt of the degree.
(A parental leave of absence can not be counted towards the four years of eligibility.)
3. Prior to submission, applicant must identify a sponsoring U.S. institution and a research mentor that is an AASLD member who agrees in writing to supervise his or her research.
4. Applicant must have a student or trainee Visa to the U.S.
5. Project is clinical. "Clinical Research" is defined as studies related to patients or disease processes having direct contact between the principal investigator and humans. Clinical research includes epidemiology and clinical trials in liver disease. At least 50 percent effort should be devoted to research activities.
6. Applicant is a member of AASLD.
7. All applications must be in English.
8. Applicant may only apply for one (1) AASLD award.
AWARD DETAILS
Award period: July 1, 2014 - June 30, 2015
One award of $75,000 will be provided for one year. Funds may only be used for salary support or technical support/laboratory supplies for the investigator. No indirect costs are provided. It is expected that additional funds are available to the applicant in order to carry out the proposed research.
Funds will be issued to the recipient's institution and are not transferable to another recipient or another institution. AASLD must approve any award transfer to an institution other than the sponsoring institution listed on the application.
Final Reports
Scientific progress and financial reports must be sent to AASLD within 60 days of completion of the award.
The Liver Meeting
The award recipient is strongly encouraged to both attend and present their work at The Liver Meeting.
SELECTION CRITERIA
Candidates will be evaluated based upon their background, their commitment to a research career, the strength of their research project and the environment in which they will conduct this project.
Applications will be reviewed based on the written materials submitted. Incomplete applications and applications that fail to adhere strictly to the instructions (including the submission deadline and page limitations) will not be reviewed. All decisions are final.
INSTRUCTIONS
1. Use the official form as a cover page. Print or type responses.
2. Include required documents and provide required signatures.
3. Put your name (last name, first name) and the name of the award in the upper right-hand corner of each page.
4. Use one-inch margins. Do not use lettering smaller than 10 point.
5. Assemble the application package in the order listed in the Required Documents section of the application.
6. Adhere to page limits and complete all sections.
7. The completed application, letters of support or commitment, and other documents as applicable must be combined into and submitted as one PDF document. Name the PDF file as follows: Last name, first initial – Award name (Example: Smith, J – LIFER)
SUBMISSION
The application deadline for this award is 11:59 pm, December 3, 2013.
Submit application in a single PDF document named as follows: Last, First intitial -Award name Example: (Smith, J - LIFER)
One copy of the complete application must be mailed to AASLD addressed as follows:
AASLD – LIFER 1001 N. Fairfax Street; Suite 400 Alexandria, VA 22314
Applicants may only submit for one (1) AASLD award or fellowship per year.
Questions may be sent to awards@aasld.org.
Urology Care Foundation/Ferring Pharmaceuticals Urology Research Success Award in Prostate Cancer Research
The application package must be SUBMITTED by email no later than 11:59 p.m. LOCAL time on Monday, July 8, 2013.
The preponderance of urologic research is funded through federal and state governments and the philanthropy of private foundations and non-profit organizations. The competition for these limited funds is extremely intense. Many projects are funded through a series of grants, thus young scientists and senior researchers may experience gaps in funding while awaiting peer review and/or approval for a new grant to support the next phase of research.
Part of the mission of the Urology Care Foundation is to expand and support research in urologic diseases. Thanks to the generosity of Ferring Pharmaceuticals, Inc., the Urology Care Foundation is proud to offer the Urology Care Foundation/Ferring Pharmaceuticals Urology Research Success Award in Prostate Cancer Research. The award will provide up to $10,000 designed to assist a urology researcher in continuing vital urology research efforts while awaiting new funding. Research supported by this award ultimately will contribute to helping those who suffer from the effects of prostate cancer.
Please submit all application docurments to grants@urologycarefoundation.org.
Request for Letters of Intent: Tuberous Sclerosis Alliance 2013 Research Grants Program
The Tuberous Sclerosis Alliance (TS Alliance) endeavors to stimulate, support and coordinate research that will lead to a cure for tuberous sclerosis complex (TSC), while improving the lives of those affected.
The TS Alliance Research Grants Program supports basic research by postdoctoral scientists and studies that accelerate the translation of basic research findings into improvements in quality of life for those affected by TSC. Researchers funded by the TS Alliance have a strong history of obtaining additional funding: between 1984 and 2010, principal investigators who received a total of $8.7 million from the TS Alliance garnered an additional $60 million from the NIH for TSC-related research and $6.9 million from the Department of Defense’s Congressionally Directed Medical Research Program.
Areas of Emphasis in 2013
Successful proposals will be those that address one or more of the following:
Developing future TSC researchers and clinician scientists through postdoctoral fellowships
Development of biomarkers to enable more robust and efficient clinical studies
Methods of eliminating tumors rather than only shrinking or stabilizing tumor growth
Neurological, cognitive, or behavioral manifestations of TSC
Key Dates
Online Submission for Letters of Intent Opens: June 1, 2013
Letters of Intent Due: June 27, 2013, at 11:59 p.m. US EDT
Full Proposal Invitations Sent by TS Alliance: July 25, 2013
Full Proposals Due (by invitation only): September 5, 2013, at 11:59 p.m. U.S. EDT
Award Notification: October 9, 2013
Earliest Funding Start Date: December 1, 2013
Funding Available
Duration: up to two years (can be shorter if appropriate for the project)
Budget limits:
Maximum total costs of $66,000 per year ($132,000 total) inclusive of both direct and indirect costs
No more than 10 percent of the total costs ($6,600 per year or $13,200 total) may be applied to indirect costs
Postdoctoral fellowship awards must include $1,000 for travel expenses to support the applicant’s professional development
The TS Alliance anticipates making three awards this year in some combination of postdoctoral fellowships or research proposals, depending on merit.
Postdoctoral fellowship awards are designed to provide funding for a PI who has recently earned a PhD or MD degree and is working with a Sponsor to do research relevant to this Request for Letters of Intent. The Sponsor must be tenure-track faculty or an equivalent level at a research institution or company. The award is intended to fund the Principal Investigator’s salary and some of the laboratory supplies or tools necessary to conduct the proposed research. The award is not intended to fund technical support for the project or to purchase equipment in the Sponsor’s laboratory.
Eligibility
This opportunity is open to all investigators at established academic or research institutions or at pharmaceutical or biotech companies worldwide. Researchers residing in the U.S. do not need to be U.S. citizens to apply for funding.
Applications will only be accepted through the online submission system.
Barth Syndrome Foundation 2013 Request for Research Proposals
The Barth Syndrome Foundation, Inc. (BSF) and its international affiliates are pleased to announce the availability of funding for basic science and clinical research on the natural history, biochemical basis, and treatment of Barth syndrome. Starting in 2013, there will be two types of grant awards: IDEA grants for 1-2 years and DEVELOPMENT grants for 2-3 years with budgetary maximums of US $50,000 or $100,000, respectively over the full period. BSF's Research Grant Program allows young, non-tenured investigators to include in their submitted budget up to 75% of the direct costs amount as PI salary (10% for established investigators). In addition, for those clinical applications where volunteers must travel to a clinical research site, these travel expenses will be handled separately and will not be included in the application budget limitation. We encourage all investigators at every professional level to submit their best ideas for advancing the state of knowledge about Barth syndrome so that progress can be made in finding a specific treatment or a cure for this unusual mitochondrial disease. There are no geographical limitations to this funding.
Barth syndrome (BTHS) is a serious X-linked genetic condition associated with cardiomyopathy, neutropenia, skeletal muscle weakness, exercise intolerance, growth delay, and diverse biochemical abnormalities (including defects in mitochondrial metabolism and phospholipid biosynthesis). Because many clinical and biochemical abnormalities of Barth syndrome remain poorly understood, we are seeking proposals for both basic science and clinical research that may shed light on any aspect of the syndrome, with the ultimate objective of developing a specific treatment or a cure.
Types of Proposals Sought
We are interested in providing financial assistance to investigators interested in exploring the field of BTHS science and/or clinical research. We anticipate that these funds might be useful as “seed grants” for the testing of initial hypotheses and the collection of preliminary data that can lead to successful long-term funding by the National Institutes of Health (NIH) and other major granting institutions around the world. In addition to those having prior research experience with BTHS, we encourage young investigators and experienced investigators that are new to the field of BTHS to submit proposals for funding.
Process
We have a competitive grant process. Applications should be of 10–15 pages in length and must follow the instructions listed on the BSF website. In general terms, detailed information about the specific aims, significance, research design and methods, personnel, facilities, and budget will be required. A one-page, “Letter of Intent” is required for DEVELOPMENT grant applicants with a due date of September 1, 2013. The “Letter of Intent” is optional for IDEA grant applicants. We strongly encourage the submission of letters of intent before the due date to allow ample time for review and feedback.
Completed applications (and/or “Letters of Intent”) will be forwarded to the BSF Scientific and Medical Advisory Board (as well as to expert outside reviewers) for confidential evaluation. Response to the “Letter of Intent” will be communicated within two weeks of receipt. Based on the recommendations of the BSF Scientific and Medical Advisory Board, the BSF Board of Directors will make the final funding decisions about the grant applications. Please review our “Grants Awarded” webpage for a listing of grants that BSF and its affiliates have awarded to date.
Funding
We anticipate awarding several IDEA and DEVELOPMENT grants each year. Funds will be available soon after the successful grant applicants have been notified in early March, 2014.
Deadline
The deadline for submission of the completed research grant application is October 31, 2013, and grants will be awarded in early March, 2014. The deadline for the one-page "Letter of Intent," if applicable, is September 1, 2013.
Contact Information
Matthew J. Toth, PhD Science Director Barth Syndrome Foundation, Inc. matthew.toth[at]barthsyndrome.org mtothbsf[at]comcast.net bsfinfo[at]barthsyndrome.org
World Federation of Hemophilia Clinical Research Grant Program
The WFH is pleased to launch its new Clinical Research Grant Program to provide support for international clinical investigation relating to inherited bleeding disorders.
The aim is to help create better evidence for the clinical management of hemophilia A and B, von Willebrand disease, rare factor deficiencies, and inherited platelet disorders. The program is peer reviewed and is open to researchers globally.
The WFH Clinical Research Grant Program will award up to four grants (two in each category) per year for the best proposals that address critical clinical issues of broad international significance.
Grant amount/duration
There are two levels of funding available:
• $10,000-$15,000 per year
• $35,000-$50,000 per year
Funding is awarded for up to two years.
An initial one-page letter of intent and a one-page CV is submitted in English. Completed forms must be sent by email to crgp_applications@wfh.org by August 31, 2013. Applications are peer reviewed by the Grant Review Committee. Successful candidates are shortlisted.
Shortlisted candidates will be notified and asked to submit a full proposal (maximum five pages) in English by December 1, 2013.
For more information, contact crgp@wfh.org.
Arthritis Foundation Investigator Award
Up to a level of $100,000 per year for no more than 5 years
Arthritis Foundation Investigator (AFI) awards provide support for an outstanding established investigator with innovative, creative ideas that have the potential to move arthritis research toward better treatments and a cure. These AFI awards are for the support of research investigations that can be accomplished within a period of up to 5 years. The awards may provide salary and/or research support. This support is available to sustain individuals committed to a pioneering career dedicated to finding better treatments and a cure for arthritis.
Application Deadline: August 30, 2013 (5:00 pm Eastern)
Peer Review September – November 2013
Funding Notification December 2013
Funding will begin January 2014 – March 2014
All applications must be submitted through proposalCENTRAL (https://proposalcentral.altum.com/)
Arthritis Foundation Innovative Research Grant
$100,000 per year up to 2 years
The purpose of the Arthritis Foundation's Innovative Research Grant (IRG) initiative is to broaden the base of inquiry in fundamental biomedical science, clinical science and bio-behavioral research with relevance to osteoarthritis (OA), rheumatoid arthritis (RA), and juvenile arthritis (JA). The ultimate goal of the program is to improve the lives of people touched by these diseases. We encourage applications for research proposals that involve an especially high degree of innovation and novelty and therefore, require a preliminary test of feasibility.
12345678910next
